231 related articles for article (PubMed ID: 24263282)
21. Abrogation of pathogenic IgG autoantibody production in CD40L gene-deleted lupus-prone New Zealand Black mice.
Pau E; Chang NH; Loh C; Lajoie G; Wither JE
Clin Immunol; 2011 May; 139(2):215-27. PubMed ID: 21414847
[TBL] [Abstract][Full Text] [Related]
22. Anti-interleukin-6 monoclonal antibody inhibits autoimmune responses in a murine model of systemic lupus erythematosus.
Liang B; Gardner DB; Griswold DE; Bugelski PJ; Song XY
Immunology; 2006 Nov; 119(3):296-305. PubMed ID: 17067309
[TBL] [Abstract][Full Text] [Related]
23. Raloxifene modulates estrogen-mediated B cell autoreactivity in NZB/W F1 mice.
Zhang Y; Saha S; Rosenfeld G; Gonzalez J; Pepeljugoski KP; Peeva E
J Rheumatol; 2010 Aug; 37(8):1646-57. PubMed ID: 20551107
[TBL] [Abstract][Full Text] [Related]
24. Subset size, activation threshold and distribution of autoreactive MZ and FO B cells do not differ in a sex-specific manner in the NZB/W F1 murine lupus model: an experimental mouse study.
Enghard P; Grussie E; Rieder C; Burmester GR; Riemekasten G
Lupus; 2011 Oct; 20(12):1240-9. PubMed ID: 21844114
[TBL] [Abstract][Full Text] [Related]
25. Plasmacytoid dendritic cells from parent strains of the NZB/W F1 lupus mouse contribute different characteristics to autoimmune propensity.
Zhan Y; Kong I; Chopin M; Macri C; Zhang JG; Xie J; Nutt SL; O'Keeffe M; Hawkins ED; Morand EF; Lew AM
Immunol Cell Biol; 2020 Mar; 98(3):203-214. PubMed ID: 31916630
[TBL] [Abstract][Full Text] [Related]
26. Requirement of dying cells and environmental adjuvants for the induction of autoimmunity.
Bondanza A; Zimmermann VS; Dell'Antonio G; Cin ED; Balestrieri G; Tincani A; Amoura Z; Piette JC; Sabbadini MG; Rovere-Querini P; Manfredi AA
Arthritis Rheum; 2004 May; 50(5):1549-60. PubMed ID: 15146425
[TBL] [Abstract][Full Text] [Related]
27. Ifi202, an IFN-inducible candidate gene for lupus susceptibility in NZB/W F1 mice, is a positive regulator for NF-kappaB activation in dendritic cells.
Yamauchi M; Hashimoto M; Ichiyama K; Yoshida R; Hanada T; Muta T; Komune S; Kobayashi T; Yoshimura A
Int Immunol; 2007 Aug; 19(8):935-42. PubMed ID: 17702989
[TBL] [Abstract][Full Text] [Related]
28. L-selectin-specific autoantibodies in murine lupus: possible involvement in abnormal homing and polarization of CD4+ T cell subsets.
Hattori S; Nishimura H; Tsurui H; Kato M; Endo N; Abe M; Akakura S; Mitsui K; Ishikawa S; Hirose S; Shirai T
J Immunol; 1998 Aug; 161(3):1231-8. PubMed ID: 9686583
[TBL] [Abstract][Full Text] [Related]
29. A subset of CD4+ T cells expressing early activation antigen CD69 in murine lupus: possible abnormal regulatory role for cytokine imbalance.
Ishikawa S; Akakura S; Abe M; Terashima K; Chijiiwa K; Nishimura H; Hirose S; Shirai T
J Immunol; 1998 Aug; 161(3):1267-73. PubMed ID: 9686587
[TBL] [Abstract][Full Text] [Related]
30. Restoration of an early, progressive defect in responsiveness to T-cell activation in lupus mice by exogenous IL-2.
Huang FP; Stott DI
Autoimmunity; 1993; 15(1):19-29. PubMed ID: 8218827
[TBL] [Abstract][Full Text] [Related]
31. Differential control of CD22 ligand expression on B and T lymphocytes, and enhanced expression in murine systemic lupus.
Lajaunias F; Ida A; Kikuchi S; Fossati-Jimack L; Martinez-Soria E; Moll T; Law CL; Izui S
Arthritis Rheum; 2003 Jun; 48(6):1612-21. PubMed ID: 12794829
[TBL] [Abstract][Full Text] [Related]
32. Interaction between antigen presenting cells and autoreactive T cells derived from BXSB mice with murine lupus.
Yang P; Li B; Lv P; Zhang Y; Gao XM
Cell Res; 2007 Jun; 17(6):556-64. PubMed ID: 17297482
[TBL] [Abstract][Full Text] [Related]
33. Successful treatment of autoimmunity in (NZB X NZW)F1 mice with cyclosporin and (Nva2)-cyclosporin: I. Reduction of autoantibodies.
Gunn HC
Clin Exp Immunol; 1986 May; 64(2):225-33. PubMed ID: 3488856
[TBL] [Abstract][Full Text] [Related]
34. Extensively re-organized systemic lymph nodes provide a feasible environment for self-reactivity in lupus-prone NZB × NZW F1 mice.
Kurosawa Y; Ozawa M; Kanda Y; Takeuchi A; Kawamura T; Narita I; Katakai T
Int Immunol; 2017 Dec; 29(12):567-579. PubMed ID: 29202179
[TBL] [Abstract][Full Text] [Related]
35. CD40-mediated stimulation of B1 and B2 cells: implication in autoantibody production in murine lupus.
Kaneko Y; Hirose S; Abe M; Yagita H; Okumura K; Shirai T
Eur J Immunol; 1996 Dec; 26(12):3061-5. PubMed ID: 8977305
[TBL] [Abstract][Full Text] [Related]
36. Critical role of TLR7 in the acceleration of systemic lupus erythematosus in TLR9-deficient mice.
Santiago-Raber ML; Dunand-Sauthier I; Wu T; Li QZ; Uematsu S; Akira S; Reith W; Mohan C; Kotzin BL; Izui S
J Autoimmun; 2010 Jun; 34(4):339-48. PubMed ID: 19944565
[TBL] [Abstract][Full Text] [Related]
37. Hyperexpression of cyclooxygenase 2 in the lupus immune system and effect of cyclooxygenase 2 inhibitor diet therapy in a murine model of systemic lupus erythematosus.
Zhang L; Bertucci AM; Smith KA; Xu L; Datta SK
Arthritis Rheum; 2007 Dec; 56(12):4132-41. PubMed ID: 18050205
[TBL] [Abstract][Full Text] [Related]
38. Suppression of glomerulonephritis in lupus-prone NZB × NZW mice by RN486, a selective inhibitor of Bruton's tyrosine kinase.
Mina-Osorio P; LaStant J; Keirstead N; Whittard T; Ayala J; Stefanova S; Garrido R; Dimaano N; Hilton H; Giron M; Lau KY; Hang J; Postelnek J; Kim Y; Min S; Patel A; Woods J; Ramanujam M; DeMartino J; Narula S; Xu D
Arthritis Rheum; 2013 Sep; 65(9):2380-91. PubMed ID: 23754328
[TBL] [Abstract][Full Text] [Related]
39. Interleukin-1 receptor-associated kinase-M suppresses systemic lupus erythematosus.
Lech M; Kantner C; Kulkarni OP; Ryu M; Vlasova E; Heesemann J; Anz D; Endres S; Kobayashi KS; Flavell RA; Martin J; Anders HJ
Ann Rheum Dis; 2011 Dec; 70(12):2207-17. PubMed ID: 21875872
[TBL] [Abstract][Full Text] [Related]
40. Dissection of the role of MHC class II A and E genes in autoimmune susceptibility in murine lupus models with intragenic recombination.
Zhang D; Fujio K; Jiang Y; Zhao J; Tada N; Sudo K; Tsurui H; Nakamura K; Yamamoto K; Nishimura H; Shira T; Hirose S
Proc Natl Acad Sci U S A; 2004 Sep; 101(38):13838-43. PubMed ID: 15361580
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
